(b)(4).No sample has been returned for investigation.The batch record could not be reviewed since the lot number is not known.Without the actual sample or lot number, a thorough investigation can not be performed.All available information has been forwarded to the actual manufacturer.If the sample, lot number and/or additional pertinent information becomes available, a follow up report will be filed.
|
As reported by the user facility (translation of user facility information by bbm sales organization in (b)(6)): phlebitis at introduction site.The hospital reported problems with introcan safety v on a (b)(6), patient initials (b)(6), implant date: (b)(6) 2015.The device was used for infusion treatment in a female patient which underwent a surgical procedure on knee prostheses on (b)(6) 2015.Since that moment till the moment in which the incident occured, physicians had been performing an infusion therapy with that device.On (b)(6) 2015 physicians noticed phlebitis at introduction site of cannula needle in right wrist (at first treated with wraps of ichthyol).On (b)(6) 2015, they noticed occurence of chest pain, dyspnea, sweating, strong pain at phlebitis site and hyperpyrexia.It was performed internist and infectious disease consulting.It was performed a computerized axial tomography on forearm with contrast medium on (b)(6) 2015 which showed a thrombophlebitis with presence of inflammatory tissue starting from dorsal area of wrist and of hand and extension intraluminal to cephalic vein.Consequence of the incident: patient hospitalization or extension of it.The device involved was 1 but not available.At discharge ((b)(6) 2015), the event was in process of recovery with antibiotic therapy prescribed by infection disease doctor.
|